Home › Liver Diseases › Arizona › Chandler
Liver Diseases clinical trials in Chandler, AZ
4 studies for Liver Diseases are looking for participants at sites in and around Chandler (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Chandler
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Chandler
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecruitingPhase 2
- Arizona Liver Health, Chandler
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
RecruitingPhase 1
- Arizona Clinical Trials - the Institute For Liver Health, Chandler
About Liver Diseases
Get the facts about liver diseases, such as hepatitis, cancer, and cirrhosis. Know your risk and what you can do to prevent liver problems.
More about Liver Diseases on MedlinePlus
Liver Diseases trials in other cities
- Houston, TX10 studies
- Chicago, IL9 studies
- Washington, DC8 studies
- Los Angeles, CA7 studies
- Atlanta, GA7 studies
- New York City, NY6 studies
- Richmond, VA6 studies
- San Antonio, TX6 studies
- Philadelphia, PA6 studies
- Dallas, TX5 studies
- Durham, NC5 studies
- Ann Arbor, MI5 studies
Other studies in Chandler
- Steatotic Liver Disease10 studies
- Breast Cancer5 studies
- Non-Small Cell Lung Cancer5 studies
- Colorectal Cancer5 studies
- Obesity5 studies
- Digestive Diseases5 studies
- Overweight4 studies
- Type 2 Diabetes4 studies
- Metastatic Cancer4 studies
- Alzheimer's Disease3 studies
- Cardiovascular Disease3 studies
- Colon Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.